27 active
/
68 total (since 2015)
7
Phase 1 Active
18 total
7
Phase 2 Active
15 total
9
Phase 3 Active
20 total
5
Phase 4 Active
20 total
Top Sponsors (Industry)
Sorted by active Active Done Failed
Addpharma Inc. 2 0 0
Resurge Therapeutics Inc. 2 0 0
Chong Kun Dang Pharmaceutical 1 6 0
Shanghai Huilun Pharmaceutical Co., Ltd. 1 1 0
ALPFA Medical 1 0 0
Eurofarma Laboratorios S.A. 1 0 0
Xintian Pharmaceutical 1 0 0
Jeil Pharmaceutical Co., Ltd. 0 3 0
NCT07209150 NOT YET RECRUITING
Randomized Controlled Trial of Different Antibiotic Duration Prior to Prostate Enucleation Surgery
Ohio State University n=250
NCT07146386 NOT YET RECRUITING
A Phase III Clinical Study of H077 Sustained-Release Tablets Compared With Silodosin Capsules in the Treatment of Benign Prostatic Hyperplasia
Shanghai Huilun Pharmaceutical Co., Ltd. n=728
NCT07017439 NOT YET RECRUITING
Investigating the Adjunctive Use of Mirabegron in the Early Post-Rezum Procedure Period
University of Manitoba n=50
NCT07017452 NOT YET RECRUITING
Trial to Assess the Efficacy and Safety During Convective Radiofrequency Water Vapor Thermal Therapy (REZUM) for Benign Prostate Hyperplasia
University of Manitoba n=48
NCT06546735 NOT YET RECRUITING
Efficacy and Safety of Two Fixed-dose Combinations in Men with Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia. (BENIPRO)
Eurofarma Laboratorios S.A. n=816
NCT06558539 NOT YET RECRUITING
Tibial Nerve Stimulation for Post-BPH Overactive Bladder
Qing Yuan n=90
NCT06491108 RECRUITING
Medications for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
Tanta University n=150
NCT05620784 RECRUITING
Intra-operative Loop Diuretics to Improve Same-day Discharge Rates After HoLEP
Northwestern University n=138
NCT04807010 NOT YET RECRUITING
PROARTE -PROstate ARTery to Reduce the Symptoms of Benign Prostatic Hyperplasia
Society of Interventional Radiology Foundation n=108
NCT04185441 COMPLETED
Efficacy and Safety of Tanzânia Association in the Treatment of Erectile Dysfunction Associated With Benign Prostatic Hyperplasia
EMS n=295
NCT06466369 COMPLETED
Administration of Tadalafil in Patients With Benign Prostatic Hyperplasia
Al-Azhar University n=306
NCT04947631 COMPLETED
Efficacy and Safety of DKF-313 in Patients With Benign Prostatic Hyperplasia
Dongkook Pharmaceutical Co., Ltd. n=667
NCT05222841 COMPLETED
The Effectiveness of Spermotrend Food Supplement in the Treatment of Male Infertility
Catalysis SL n=150
NCT05531344 COMPLETED
Composite Steep-pulseTreatment Device Used in Patients With Benign Prostatic Hyperplasia
REMD Medical Technology n=160
NCT04032067 COMPLETED
Evaluate the Efficacy and Safety of GV1001 in Patients With Benign Prostatic Hyperplasia (BPH)
GemVax & Kael n=423
NCT02869971 COMPLETED
Prostatic Artery Embolization Versus Medical Treatment in Symptomatic Benign Prostatic Hyperplasia
Assistance Publique - Hôpitaux de Paris n=90
NCT04263987 COMPLETED
A Comparison of Traditional and MOSES Laser Enucleation of the Prostate (MOLEP): A Prospective, Randomized, Double-blinded Control Trial A Comparison of Traditional and MOSES Laser Enucleation of the Prostate (MOLEP): A Prospective, Randomized, Double-blinded Control Trial
Vanderbilt University Medical Center n=60
NCT02972268 COMPLETED
Clinical Trial to Compare the Solifenacin/Tamsulosin Combination Therapy With Tamsulosin Monotherapy for LUTS Due to BPH
Jeil Pharmaceutical Co., Ltd. n=780
NCT03246880 COMPLETED
Clinical Trial To Evaluate the Efficacy and Safety of CKD-397 in Benign Prostatic Hyperplasia Patients
Chong Kun Dang Pharmaceutical n=455
NCT02667938 COMPLETED
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HCP1303 Capsules
Hanmi Pharmaceutical Company Limited n=510
Data: ClinicalTrials.gov